DrugPatentWatch Database Preview
Details for Patent: 8,618,141
Email this page to a colleague
» See Plans and PricingWhich drugs does patent 8,618,141 protect, and when does it expire?
Patent 8,618,141 protects NEXAVAR and is included in one NDA.
This patent has fifteen patent family members in eleven countries.
Summary for Patent: 8,618,141
| Title: | Aryl ureas with angiogenesis inhibiting activity |
| Abstract: | This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| Inventor(s): | Dumas; Jacques (Bethany, CT), Scott; William J. (Guilford, CT), Elting; James (Madison, CT), Hatoum-Makdad; Holia (Hamden, CT) |
| Assignee: | Bayer Healthcare LLC (Whippany, NJ) |
| Application Number: | 13/551,884 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,618,141 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 8,618,141
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | NEXAVAR | sorafenib tosylate | TABLET;ORAL | 021923-001 | Dec 20, 2005 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF ADVANCED RENAL CELL CARCINOMA | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,618,141
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003209116 | Start Trial | |||
| Canada | 2475703 | Start Trial | |||
| Cyprus | 1114314 | Start Trial | |||
| Denmark | 1478358 | Start Trial | |||
| European Patent Office | 1478358 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
